Zimbabwe has declined a significant American healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of Washington's request for confidential data.
This rejection became public after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson later clarified that the US was seeking biological samples for scientific study and profit while was not willing to share the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged more talks to reach a deal agreeable to all parties so the nation's vital HIV programme can proceed.
Wider Implications
This development follows a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement after legal challenges were raised about the security of citizens' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
Based on statements, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Effectively, our country would provide the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people if a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures already set up via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.
"This mechanism is designed to guarantee that when a country provides its information, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how future collaboration might be designed in a way that honours the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body said it acknowledged the government's concerns, but urged that negotiations must proceed given that much of the country's Aids initiatives depended on external financing.
"In cases where specific concerns exist, such as those relating to information security or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group added.
The situation highlights the ongoing tensions between receiving crucial international aid and protecting national sovereignty in an ever more interconnected world.